U.S. markets closed
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • Dow 30

    35,294.76
    +382.20 (+1.09%)
     
  • Nasdaq

    14,897.34
    +73.91 (+0.50%)
     
  • Russell 2000

    2,265.65
    -8.52 (-0.37%)
     
  • Crude Oil

    82.66
    +1.35 (+1.66%)
     
  • Gold

    1,768.10
    -29.80 (-1.66%)
     
  • Silver

    23.35
    -0.13 (-0.54%)
     
  • EUR/USD

    1.1606
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • GBP/USD

    1.3751
    +0.0074 (+0.54%)
     
  • USD/JPY

    114.2000
    +0.5230 (+0.46%)
     
  • BTC-USD

    60,918.19
    +1,172.07 (+1.96%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     
  • Nikkei 225

    29,068.63
    +517.70 (+1.81%)
     

Baxter to Acquire Hillrom At $156/Share: See The Highlights

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Baxter International Inc (NYSE: BAX) has agreed to acquire Hill-Rom Holdings Inc (NYSE: HRC) for $156.00 per share in cash, slightly higher than the earlier anticipated $150.

  • Related Content: Baxter In Advanced Talks For B Hill Rom Buyout

  • The deal values HRC's equity at approximately $10.5 billion and a total enterprise value of roughly $12.4 billion, including the assumption of debt.

  • The purchase price represents a 26% premium to Hillrom's closing stock price on July 27, the last trading day before media reports speculating about a potential transaction.

  • Baxter expects the combination to result in approximately $250 million of annual pre-tax cost synergies by the end of year three.

  • The transaction is expected to be low double-digit accretive to Baxter's adjusted earnings per share in the first full year post-close, increasing to more than 20% by year three.

  • The transaction is also expected to expand Baxter's overall adjusted EBITDA margins over the medium-term and deliver strong cash flow generation with a high single-digit return on invested capital expected by year five.

  • Baxter will finance the transaction through a combination of cash and debt financing. As of June 30, cash and cash equivalents stood at around $3.1 billion (See June 10Q here).

  • At closing, Baxter estimates that it will have net leverage of approximately 4.2x net debt to pro forma adjusted EBITDA of the combined companies.

  • The transaction is expected to close by early 2022.

  • Price Action: HRC stock is up 3.82% at $150.06, and BAX stock is up 1.55% at $78.80 during the premarket session on the last check Thursday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.